The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
17β-Estradiol Reduces Stroke Injury in Estrogen-Deficient Female Animals
Open accessAbstract
Background and Purpose —The importance of postmenopausal estrogen replacement therapy for stroke in females remains controversial. We previously showed that female rats sustain less infarction in reversible middle cerebral artery occlusion (MCAO) than their ovariectomized counterparts and that vascular mechanisms are partly responsible for improved tissue outcomes. Furthermore, exogenous estrogen strongly protects the male brain, even when administered in a single injection before MCAO injection. The present study examined the hypothesis that replacement of 17β-estradiol to physiological levels improves stroke outcome in ovariectomized, estrogen-deficient female rats, acting through blood flow–mediated mechanisms. Methods —Age-matched, adult female Wistar rats were ovariectomized and treated with 0, 25, or 100 μg of 17β-estradiol administered through a subcutaneous implant or with a single Premarin (USP) injection (1 mg/kg) given immediately before ischemia was induced (n=10 per group). Each animal subsequently underwent 2 hours of MCAO by the intraluminal filament technique, followed by 22 hours of reperfusion. Ipsilateral parietal cortex perfusion was monitored by laser-Doppler flowmetry throughout ischemia. Cortical and caudate-putamen infarction volumes were determined by 2,3,5-triphenyltetrazolium chloride staining and digital image analysis. End-ischemic regional cerebral blood flow was measured in ovariectomized females with 0- or 25-μg implants (n=4 per group) by 14 C-iodoantipyrine quantitative autoradiography. Results —Plasma estradiol levels were 3.0±0.6, 20±8, and 46±10 pg/mL in the 0-, 25-, and 100-μg groups, respectively. Caudate-putamen infarction (% of ipsilateral caudate-putamen) was reduced by long-term, 25-μg estrogen treatment (13±4% versus 31±6% in the 0-μg group, P <0.05, and 22±3% in the 100-μg group). Similarly, cortical infarction (% of ipsilateral cortex) was reduced only in the 25-μg group (3±2% versus 12±3% in the 0-μg group, P <0.05, and 6±3% in the 100-μg group. End-ischemic striatal or cortical blood flow was not altered by estrogen treatment at the neuroprotective dose. Infarction volume was unchanged by acute treatment before MCAO when estrogen-treated animals were compared with saline vehicle–treated animals. Conclusions —Long-term estradiol replacement within a low physiological range ameliorates ischemic brain injury in previously ovariectomized female rats. The neuroprotective mechanism is flow-independent, not through preservation of residual ischemic regional cerebral blood flow. Furthermore, the therapeutic range is narrow, because the benefit of estrogen in transient vascular occlusion is diminished at larger doses, which yield high, but still physiologically relevant, plasma 17β-estradiol levels. Lastly, unlike in the male brain, single-injection estrogen exposure does not salvage ischemic tissue in the female brain. Therefore, although exogenous steroid therapy protects both male and female estrogen-deficient brain, the mechanism may not be identical and depends on long-term hormone augmentation in the female.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reversible middle cerebral artery occlusion without craniectomy in rats.
Longa, E. Z., Weinstein, P. R., Carlson, S., & Cummins, R. (1989) · Stroke · doi:10.1161/01.str.20.1.84 · Cited by 7,463
Kuiper, G. G. J. M., Carlsson, B., Grandien, K., Enmark, E., Häggblad, J., Nilsson, S., & Gustafsson, J.-A. (1997) · Endocrinology · doi:10.1210/endo.138.3.4979 · Cited by 4,442
ERβ: Identification and characterization of a novel human estrogen receptor
Mosselman, S., Polman, J., & Dijkema, R. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00782-x · Cited by 2,269
Simerly, R. B., Swanson, L. W., Chang, C., & Muramatsu, M. (1990) · Journal of Comparative Neurology · doi:10.1002/cne.902940107 · Cited by 2,118
BUTCHER, R. L., COLLINS, W. E., & FUGO, N. W. (1974) · Endocrinology · doi:10.1210/endo-94-6-1704 · Cited by 1,308
Postmenopausal Hormone Therapy and Mortality
Grodstein, F., Stampfer, M. J., Colditz, G. A., Willett, W. C., Manson, J. E., Joffe, M., Rosner, B., Fuchs, C., Hankinson, S. E., Hunter, D. J., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199706193362501 · Cited by 1,184
Woolley, C., & McEwen, B. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-07-02549.1992 · Cited by 990
Measurement of local cerebral blood flow with iodo [14C] antipyrine
Sakurada, O., Kennedy, C., Jehle, J., Brown, J. D., Carbin, G. L., & Sokoloff, L. (1978) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1978.234.1.h59 · Cited by 926
Cardiovascular Health and Disease in Women
Wenger, N. K., Speroff, L., & Packard, B. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307223290406 · Cited by 801
Gender-Linked Brain Injury in Experimental Stroke
Alkayed, N. J., Harukuni, I., Kimes, A. S., London, E. D., Traystman, R. J., & Hurn, P. D. (1998) · Stroke · doi:10.1161/01.str.29.1.159 · Cited by 753
Self-citationThe vascular protective effects of estrogen
Farhat, M. Y., Lavigne, M. C., & Ramwell, P. W. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.5.8621060 · Cited by 639
Estradiol reduces calcium currents in rat neostriatal neurons via a membrane receptor
Mermelstein, P., Becker, J., & Surmeier, D. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-02-00595.1996 · Cited by 632
Wilson, P. W. F., Garrison, R. J., & Castelli, W. P. (1985) · New England Journal of Medicine · doi:10.1056/nejm198510243131702 · Cited by 601
Estradiol Protects against Ischemic Injury
Dubal, D. B., Kashon, M. L., Pettigrew, L. C., Ren, J. M., Finklestein, S. P., Rau, S. W., & Wise, P. M. (1998) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199811000-00012 · Cited by 554
Simpkins, J. W., Rajakumar, G., Zhang, Y.-Q., Simpkins, C. E., Greenwald, D., Yu, C. J., Bodor, N., & Day, A. L. (1997) · Journal of Neurosurgery · doi:10.3171/jns.1997.87.5.0724 · Cited by 509
Estrogen Receptors: Bioactivities and Interactions with Cell Signaling Pathways1
Katzenellenbogen, B. S. (1996) · Biology of Reproduction · doi:10.1095/biolreprod54.2.287 · Cited by 374
Estrogen-Mediated Neuroprotection After Experimental Stroke in Male Rats
Toung, T. J. K., Traystman, R. J., & Hurn, P. D. (1998) · Stroke · doi:10.1161/01.str.29.8.1666 · Cited by 364
Self-citationTilly, J. L., Tilly, K. I., Kenton, M. L., & Johnson, A. L. (1995) · Endocrinology · doi:10.1210/en.136.1.232 · Cited by 363
Cardiovascular disease in women.
Eaker, E. D., Chesebro, J. H., Sacks, F. M., Wenger, N. K., Whisnant, J. P., & Winston, M. (1993) · Circulation · doi:10.1161/01.cir.88.4.1999 · Cited by 347
Postmenopausal oestrogen treatment and stroke: a prospective study.
Paganini-Hill, A., Ross, R. K., & Henderson, B. E. (1988) · BMJ · doi:10.1136/bmj.297.6647.519 · Cited by 344
Estrogen and the blood vessel wall
Mendelsohn, M. E., & Karas, R. H. (1994) · Current Opinion in Cardiology · doi:10.1097/00001573-199409000-00018 · Cited by 313
Estradiol-Concentrating Neurons: Topography in the Hypothalamus by Dry-Mount Autoradiography
Stumpf, W. E. (1968) · Science · doi:10.1126/science.162.3857.1001 · Cited by 298
The distribution of estrogen receptor-β mRNA in the rat hypothalamus
Shughrue, P. J., Komm, B., & Merchenthaler, I. (1996) · Steroids · doi:10.1016/s0039-128x(96)00222-x · Cited by 288
Nequin, L. G., Alvarez, J., & Schwartz, N. B. (1979) · Biology of Reproduction · doi:10.1095/biolreprod20.3.659 · Cited by 283
Sex Differences in Postischemic Neuronal Necrosis in Gerbils
Hall, E. D., Pazara, K. E., & Linseman, K. L. (1991) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1991.61 · Cited by 255
Arnal, J. F., Clamens, S., Pechet, C., Negre-Salvayre, A., Allera, C., Girolami, J. P., Salvayre, R., & Bayard, F. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.4108 · Cited by 254
Decreased risk of stroke among postmenopausal hormone users. Results from a national cohort
Finucane, F. F. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.153.1.73 · Cited by 245
Wang, Q., Santizo, R., Baughman, V. L., & Pelligrino, D. A. (1999) · Stroke · doi:10.1161/01.str.30.3.630 · Cited by 170
Progestogens and arterial disease—Evidence from the Royal College of General Practitioners' study
Kay, C. R. (1982) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(16)32485-1 · Cited by 162
Steroid Hormone Actions on the Brain: When Is the Genome Involved?
McEwen, B. S. (1994) · Hormones and Behavior · doi:10.1006/hbeh.1994.1036 · Cited by 154
Postischemic Cerebral Blood Flow Recovery in the Female: Effect of 17β-Estradiol
Hurn, P. D., Littleton‐Kearney, M. T., Kirsch, J. R., Dharmarajan, A., & Traystman, R. J. (1995) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1995.82 · Cited by 150
Self-citationCerebral vasodilating capacity during forebrain ischemia
Pelligrino, D. A., Santizo, R. A., Baughman, V. L., & Wang, Q. (1998) · Neuroreport · doi:10.1097/00001756-199810050-00026 · Cited by 144
bcl‐2 expression in normal breast tissue during the menstrual cycle
Sabourin, J., Martin, A., Baruch, J. M., et al. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910590102 · Cited by 129
Skipper, J. K., Young, L. J., Bergeron, J. M., Tetzlaff, M. T., Osborn, C. T., & Crews, D. P. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.15.7172 · Cited by 111
Ischemic Stroke and Use of Estrogen and Estrogen/Progestogen as Hormone Replacement Therapy
Petitti, D. B., Sidney, S., Quesenberry, C. P., & BERNSTEIN, A. L. (1998) · Stroke · doi:10.1161/01.str.29.1.23 · Cited by 100
Non-genomic effects of estrogen and the vessel wall
Farhat, M. Y., Abi-Younes, S., & Ramwell, P. W. (1996) · Biochemical Pharmacology · doi:10.1016/s0006-2952(95)02159-0 · Cited by 91
Differential effects of low- and high-dose estrogen treatments on vascular responses in female rats
Bolego, C., Cignarella, A., Ruzza, R., Zaarour, C., Messi, E., ZANISI, M., & Puglisi, L. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00284-1 · Cited by 54
Cited by
Garcia-Segura, L. M., Azcoitia, I., & DonCarlos, L. L. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00025-3 · Cited by 938
ROOF, R. L., & HALL, E. D. (2000) · Journal of Neurotrauma · doi:10.1089/neu.2000.17.367 · Cited by 655
Neurotrophic and neuroprotective actions of estrogen: Basic mechanisms and clinical implications
Brann, D. W., Dhandapani, K., Wakade, C., Mahesh, V. B., & Khan, M. M. (2007) · Steroids · doi:10.1016/j.steroids.2007.02.003 · Cited by 647
Estrogen receptor α, not β, is a critical link in estradiol-mediated protection against brain injury
Dubal, D. B., Zhu, H., Yu, J., Rau, S. W., Shughrue, P. J., Merchenthaler, I., Kindy, M. S., & Wise, P. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1952 · Cited by 547
Influence of sex steroid hormones on cerebrovascular function
Krause, D. N., Duckles, S. P., & Pelligrino, D. A. (2006) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01095.2005 · Cited by 431
Metadata
- Authors
- Rusa, R., Alkayed, N. J., Crain, B. J., Traystman, R. J., Kimes, A. S., London, E. D., Klaus, J. A., & Hurn, P. D.
- Venue
- Stroke
- Published
- 1999-08
- Volume
- 30
- Issue
- 8
- Pages
- 1665-1670
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W1862183284
- Cited by
- 304
- References
- 37
- FWCI
- 10.47
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.